Global Coalition on Aging and Novim Join Forces to Create The Alliance To Beat COVID-19 (ABC): A Partnership to Build the Trust and Confidence to Defeat our Global Pandemic

New York, New York (December 18, 2020) – The Global Coalition on Aging (GCOA), the world’s leading business voice on aging, and science-based communications firm Novim today announced our innovative partnership – Alliance to Beat COVID (ABC) – to advance the goals of COVID-19 immunization for all. As two leaders in science and health strategy, Novim and GCOA are joining forces in our ABC campaign for an effective communication and education strategy that will help global society build trust in COVID-19 vaccines so that everyone around the globe will be confident and motivated to “get vaccinated.”

“There are five essential steps for the COVID-19 vaccine to work effectively: First, do no harm, ensure it is safe. Second, make sure it’s effective. Third, create sufficient scaled manufacturing to produce enough vaccine for all. Fourth, power a distribution system to get the vaccines to us. And fifth, get us to actually take it,” said Michael Hodin, CEO, Global Coalition on Aging.  “Stunningly, it is the fifth that will prove the greatest barrier as we see COVID-19 vaccine reluctance skyrocketing across our planet.”

Trust in the science of COVID-19 vaccine innovation follows a paradoxically well-known path where medicines generally, vaccines in particular and adult vaccines even more, are too often unused. According to a recent World Health Organization report, information, an enabling environment, social influence, and motivation influence vaccine acceptance. We live in a world in which, as the Annals of Internal Medicine reports, all medicine compliance is under 50%. For adult vaccines, it’s even worse, with only 37% of American adults vaccinated against the flu. The WHO reports that in the EU, just 60% of adults have received commonly recommended vaccinations, and in Australia, only half of the over-65 population has been vaccinated for flu and pneumococcal pneumonia. Even in super-aging Japan, where prevention and healthy aging are priorities for the population overall and rates of vaccine-preventable diseases like pneumococcal pneumonia are high, there persists remarkably low compliance. Compounding the reluctance further is the growing antivax and vaccine skeptics movements and the politicization of the COVID-19 vaccine.

“For our part,” said Michael Ditmore, Executive Director of Novim, “we will put our expertise in science, research, and analysis to evaluate and communicate on complex, complicated global scientific issues to the challenge of our moment – communicating the necessity and benefits of global immunization to Covid-19.”

For more information on the Alliance to Beat COVID, and how you can help, go to https://alliancetobeatcovid.org.

About Novim

Novim was founded in January of 2008 at the Kavli Institute for Theoretical Physics, at UC Santa Barbara, California with a mission to assemble teams of scientists to render complex issues comprehensible to non-scientists. These projects and studies are short duration efforts on a wide variety of subjects, delivering reports and web and mobile applications that help explain subjects ranging from nuclear power to pension reform to climate change.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Women, Work, Wellness, and That Aging Thing…

The OECD Forum’s virtual event Women at The Frontline of the Recovery will presciently focus attention among policymakers and the public stakeholders alike on the unique relationship between the age demographic mega-trend and the essential policies needed for OECD economies to emerge from the COVID-19 pandemic.

Headlines of the Future Podcast: Decoding Healthy Aging

How can advancements in science and medicine make it possible for individuals to enjoy greater health and activity in their later years? For health leaders and organizations such as the Global Coalition on Aging, ensuring individuals can truly shine in their "Golden Years" is a matter of revisiting education and communication strategies, advancing digital health technologies and expanding access to healthcare innovation.

Longer Lifespans Require Secure Financial Futures

As many as half of 5-year-olds in the United States can now expect to live to 100, a population that is projected to swell in the decades ahead. Longer lifespans don’t guarantee a financially secure later life, however. If anything, in the absence of significant planning, extreme longevity may make financial security harder to attain.

Financial Times Letter to the Editor

The call by Messrs Mario Draghi and Emmanuel Macron for a new growth strategy under France’s EU presidency should be guided by three principles aligned with their point about “demographic evolutions changing the structure of our societies” (Opinion, December 24).

Health Equity and Innovation Are at Risk for All of Us

The rapid development of COVID-19 vaccines illustrates what’s possible when federal policy fosters innovation with a real public-private partnership, especially for the health challenges facing America’s more than 54 million older adults. Yet, a number of drug-pricing policy proposals now jeopardize this very model, threatening to limit access to prescription drugs, compromise health equity and slow progress on urgently needed new treatments for age-related chronic conditions.